Building ecosystems to advance precision medicine
Leveraging a decade of machine learning expertise with clinical, genomic, and SDoH datasets, Decode convenes ecosystems of pharmaceutical, diagnostic, and technology partners that drive radical collaboration and jumpstart ROI.
Decode Health accelerates discovery
Helping solve healthcare data problems, from genomics to population health
Ecosystem partners benefit from Decode’s cumulative know-how, gained over years of honing AI methods through hundreds of use cases. We help our partners leapfrog the challenges involving data structure, modeling and outcomes assessment.
Define
Assess risks
Evaluate data/sources
Target opportunities to unlock value
Develop
Unite data from static, live, and/or real time SMS sources
Enrich with SDOH and existing datasets
Build AI models to detect and predict patterns
Reveal
Illuminate patterns in context
Stratify risks and opportunities
Predict and prepare for what’s next
Repeat
Iterate models with incoming data
Evolve and assimilate as data increases
Optimize and grow ROI and value with time
Data. Products. Services.
We are a partner and collaborator, not just a consultant. Our ecosystem expands access to teams working on similar challenges and facilitates connections to new collaborations and customer relationships. Our work is fast, accurate and scalable.
Speed to Value
We continuously mature our approach – deploying cutting edge technology while building an ecosystem of partners that can collectively solve challenges together. The result? Decode helps companies complete strategic analyses 8-10x faster than alternative approaches.
Delivering innovation without an army of data scientists.
Together, our work produces operational solutions for internal and external revenue generation. Below are three examples of the ecosystem at work.
Decoding Genomics and RNA
Biomarker-driven clinical trials are 2-5X more likely to succeed.
Partnering with Quest Diagnostics, we are identifying novel biomarkers to predict disease risk and monitor ongoing disease. While the biomarker research expands, Decode is producing a powerful combination of licensable data assets and technical processes to enhance drug discovery and monitoring.
Decoding Population Health
Predictive models identify oncology treatment intolerance.
Working with an international pharmaceutical company, Decode is building predictive models to define unique oncology patient personas to understand chemotherapy intolerance. These insights will help refine future clinical trials and offer clinical decision support tools that guide treatment selection to improve outcomes.
Decoding Public Health Emergencies
SDoH-driven models enable better testing and treatment planning.
Collaborating with governmental agencies, Decode’s SDoH-driven models will identify the highest risk populations, with context. These insights allow agencies to target resources for testing and treatment to the highest risk geographies and populations, while improving health equity. During the Covid pandemic, we built models to predict outcomes and identify barriers to treatment, helping local agencies mitigate spread.
